GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.360
-0.020 (-0.84%)
At close: Apr 28, 2026, 4:00 PM EDT
2.350
-0.010 (-0.42%)
After-hours: Apr 28, 2026, 7:47 PM EDT
GRI Bio Employees
GRI Bio had 4 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,989,000
Market Cap
3.41M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4 | 0 | - |
| Dec 31, 2024 | 4 | 0 | - |
| Dec 31, 2023 | 4 | 3 | 300.00% |
| Dec 31, 2022 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Tivic Health Systems | 52 |
| Jaguar Health | 47 |
| HCW Biologics | 36 |
| GeoVax Labs | 17 |
| Azitra | 13 |
| Decoy Therapeutics | 11 |
| Ensysce Biosciences | 10 |
| Artelo Biosciences | 7 |
GRI News
- 20 days ago - GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions - GlobeNewsWire
- 2 months ago - GRI Bio CEO, Marc Hertz, Featured in Virtual Investor “What This Means” Segment - GlobeNewsWire
- 2 months ago - GRI Bio Transcript: Corporate Connect Webinar Series - Transcripts
- 2 months ago - GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial - GlobeNewsWire
- 2 months ago - GRI Bio Reiterates Full Year 2025 Financial Results, Strengthens Balance Sheet and Summarizes Key Recent Highlights - GlobeNewsWire
- 3 months ago - GRI Bio Delivers Compelling New Phase 2a Gene Expression Data Demonstrating Improvements in Key Drivers of Fibrosis and Lung Repair in IPF - GlobeNewsWire
- 3 months ago - GRI Bio Announces Reverse Stock Split - GlobeNewsWire
- 3 months ago - GRI Bio Transcript: EGM 2026 - Transcripts